I've been on the low-FODMAP diet for 6 weeks. Here are 6 of my favorite Trader Joe's grocery staples.
Six weeks ago, I started the low-FODMAP diet to help improve my gut health and reduce inflammation.
I love shopping at Trader Joe's for diet-friendly staples.
Blueberries, chia seeds, and carrot juice are a few of my favorite items to buy.
About six weeks ago, I started the low-FODMAP diet in an effort to improve my gut health.
The diet entails cutting out foods high in short-chain carbohydrates (fermentable oligosaccharides, disaccharides, monosaccharide, and polyols). These carbs can cause digestive issues for people with functional gut disorders, like IBS.
I started the elimination phase of the diet by avoiding high-FODMAP foods like dairy-based milk, wheat-based bread, garlic, and apples.
Although the diet initially felt overwhelming and restrictive, I was pleased to learn that Trader Joe's has a variety of low-FODMAP options.
From blueberries and carrot juice to peanut butter, here are six of my favorite FODMAP-friendly staples.
Blueberries are a key ingredient in my morning breakfasts.
Blueberries are low in fructose, which makes them great for the low-FODMAP diet. I enjoy adding them to diet-friendly versions of pancakes.
Chia seeds are the star of my 15-minute pudding recipe.
Every night, I make homemade chia-seed pudding by refrigerating a mix of chia seeds, almond milk, and maple syrup in a glass jar.
I like to make this because a small serving of chia seeds is low in FODMAPs. Almond milk is lactose free, which also makes it good for low-FODMAP diets, and maple syrup is considered a better low-FODMAP alternative to other sweeteners like honey.
Overall, it's a great, convenient breakfast option that leaves me feeling satisfied.
Peanut butter is high in protein and healthy fats.
In addition to spreading peanut butter on low-FODMAP-friendly bagels, I like to pair it with fruit and celery for an easy snack.
Trader Joe's unsalted peanut butter contains just one ingredient: peanuts. Compared to other nuts like cashews and pistachios, peanuts are low in fermentable carbs.
I like to use organic brown-rice penne as the base for my homemade pesto pasta.
Pastas made from rice are better for my low-FODMAP diet than standard wheat-based pastas, which are higher in fructans. So, I like to pick up Trader Joe's organic brown-rice pasta.
To make my pesto sauce low-FODMAP, too, I omit garlic from the recipe and substitute pine nuts with walnuts.
Organic carrot juice is high in vitamin A, antioxidants, and minerals.
Although I recently purchased a juicer, I like to grab Trader Joe's organic carrot juice when I'm on the go.
Carrots are low in fructans and mannitol, making them good for the low-FODMAP diet.
Organic white-corn tortilla chips make a great base for homemade nachos.
I use Trader Joe's organic white-corn tortilla chips as the base for my 20-minute nacho recipe, which also includes grilled or sautéed chicken and some avocado.
Unlike tortilla chips made from wheat flour, which are high in fructans, corn-based tortilla chips don't have as many fructans.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
a day ago
- Business Insider
I've been on the low-FODMAP diet for 6 weeks. Here are 6 of my favorite Trader Joe's grocery staples.
Six weeks ago, I started the low-FODMAP diet to help improve my gut health and reduce inflammation. I love shopping at Trader Joe's for diet-friendly staples. Blueberries, chia seeds, and carrot juice are a few of my favorite items to buy. About six weeks ago, I started the low-FODMAP diet in an effort to improve my gut health. The diet entails cutting out foods high in short-chain carbohydrates (fermentable oligosaccharides, disaccharides, monosaccharide, and polyols). These carbs can cause digestive issues for people with functional gut disorders, like IBS. I started the elimination phase of the diet by avoiding high-FODMAP foods like dairy-based milk, wheat-based bread, garlic, and apples. Although the diet initially felt overwhelming and restrictive, I was pleased to learn that Trader Joe's has a variety of low-FODMAP options. From blueberries and carrot juice to peanut butter, here are six of my favorite FODMAP-friendly staples. Blueberries are a key ingredient in my morning breakfasts. Blueberries are low in fructose, which makes them great for the low-FODMAP diet. I enjoy adding them to diet-friendly versions of pancakes. Chia seeds are the star of my 15-minute pudding recipe. Every night, I make homemade chia-seed pudding by refrigerating a mix of chia seeds, almond milk, and maple syrup in a glass jar. I like to make this because a small serving of chia seeds is low in FODMAPs. Almond milk is lactose free, which also makes it good for low-FODMAP diets, and maple syrup is considered a better low-FODMAP alternative to other sweeteners like honey. Overall, it's a great, convenient breakfast option that leaves me feeling satisfied. Peanut butter is high in protein and healthy fats. In addition to spreading peanut butter on low-FODMAP-friendly bagels, I like to pair it with fruit and celery for an easy snack. Trader Joe's unsalted peanut butter contains just one ingredient: peanuts. Compared to other nuts like cashews and pistachios, peanuts are low in fermentable carbs. I like to use organic brown-rice penne as the base for my homemade pesto pasta. Pastas made from rice are better for my low-FODMAP diet than standard wheat-based pastas, which are higher in fructans. So, I like to pick up Trader Joe's organic brown-rice pasta. To make my pesto sauce low-FODMAP, too, I omit garlic from the recipe and substitute pine nuts with walnuts. Organic carrot juice is high in vitamin A, antioxidants, and minerals. Although I recently purchased a juicer, I like to grab Trader Joe's organic carrot juice when I'm on the go. Carrots are low in fructans and mannitol, making them good for the low-FODMAP diet. Organic white-corn tortilla chips make a great base for homemade nachos. I use Trader Joe's organic white-corn tortilla chips as the base for my 20-minute nacho recipe, which also includes grilled or sautéed chicken and some avocado. Unlike tortilla chips made from wheat flour, which are high in fructans, corn-based tortilla chips don't have as many fructans.
Yahoo
3 days ago
- Yahoo
6 toilet habit changes you should always see a doctor about
No one enjoys talking about bowel movements. But ignoring the signs your body is trying to send you can mean putting off a diagnosis you really need to hear. Just ask TOWIE star Chloe Meadows. The reality TV regular recently shared on Dr Oscar Duke's Bedside Manners podcast that she'd spent a decade silently struggling with bleeding, stomach pain and extreme fatigue before finally getting a diagnosis: ulcerative colitis, a chronic condition that causes inflammation and ulcers in the colon. She lived with on-and-off symptoms for years, assuming they'd passed. It wasn't until age 26, when she became visibly unwell, that a blood test led her to A&E and finally, a diagnosis. Meadows' experience is an important reminder that when your toilet habits change – and stay changed – it's time to talk to your GP. Below, we break down six toilet-related red flags that experts say you should never ignore. And no, it's not just about your bowel movements; your wee, urgency levels, and even smells all matter, too. Whether you're suddenly constipated, dealing with constant diarrhoea, or noticing your stool looks different (narrower, paler or greasy), changes that last longer than a few weeks are worth investigating. The NHS advises that ongoing shifts in bowel habits could be linked to anything from diet and stress to Irritable Bowel Syndrome (IBS), coeliac disease or inflammatory bowel disease (IBD). In some cases, persistent symptoms could be a sign of bowel cancer, so don't brush them off. When to see your GP: If your usual routine has changed for more than two to three weeks, especially if it's paired with stomach pain, fatigue, or weight loss. It might be bright red or dark and tarry; either way, it's not something to ignore. Bright red blood can come from piles or small tears, but darker blood might mean there's bleeding higher up in the digestive system. When to see your GP: If you see blood in your poo. You may be offered a stool test, or in some cases, a referral for further checks. If anything feels amiss and suddenly starts to sting, burn or feel uncomfortable, you might assume it's a urinary tract infection (UTI). And often, that's true. But it can also be a sign of kidney stones or bladder issues. Blood in your urine should also be taken seriously, even if it only happens once. When to see your GP: If you have pain while urinating, see blood or feel the urge to go far more often than usual. Needing the loo more often than usual (especially at night), feeling like you can't wait, or leaking a little when you cough, sneeze or laugh could signal an overactive bladder, prostate issues (in men), or pelvic floor dysfunction. These symptoms might feel embarrassing, but they're generally common and manageable with the right support. When to see your GP: If bladder leaks or urgency interfere with your daily life, or if you notice a sudden change in how often you need to go. A little mucus in your stool isn't always a worry, but frequent slimy stools can be a sign of infection or inflammation in your gut. When to see your GP: If mucus appears regularly, especially if it comes with bloating, pain or a change in bowel movements. If going to the toilet has become uncomfortable, painful, or feels like hard work, that's your body waving a red flag. Regular straining can cause or worsen hemorrhoids, but it might also signal bowel issues or even neurological problems affecting your pelvic floor. When to see your GP: If you're straining often, feel like you're not fully emptying your bowels, or notice pain during or after a bowel movement. If you're unsure, remember that everyone has their own baseline of what's 'normal'. However, there are a few simple signs to watch for as a guide. According to the Bladder and Bowel Health Service, healthy bowel movements should be soft, smooth and easy to pass; ideally at least three times a week. You should also be able to urinate without pain or discomfort. If you also notice you're often bloated, tired, straining, or notice blood or mucus, it's time to speak to your GP. Changes might be harmless, but they're always worth checking. Read more on bowel habits: This Poop Chart Will Tell You If Your Bathroom Habits Are Actually Healthy Or If You Need To See A Doctor ASAP (Buzzfeed, 4-min read) How 'blowing bubbles' and 'mooing' can help ease constipation, according to NHS doctor (Yahoo Life UK, 4-min read) Bowel cancer cases in young people rising sharply in England, study finds (PA Media, 4-min read)
Yahoo
5 days ago
- Yahoo
NeurAxis Achieves Critical Milestone; Secures Key Academic Society Guidelines Recommendation for Treatment of Functional Abdominal Pain (FAP) in IBS
Practice guidelines published in the Journal of Pediatric Gastroenterology & Nutrition (JPGN) name Percutaneous Electrical Nerve Field Stimulation (PENFS) as a recommended treatment option for FAP in IBS NeurAxis's PENFS technology is the only FDA-cleared or approved treatment that is recommended in the guidelines for pediatrics, enabling momentum for large-scale insurance coverage for IB-Stim® CARMEL, Ind., June 10, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. ('NeurAxis,' or the 'Company') (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, today announced that its proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology has been officially incorporated into newly released clinical practice guidelines issued by the leading pediatric academic society for the treatment of Functional Abdominal Pain (FAP) in Irritable Bowel Syndrome (IBS). This inclusion represents a major catalyst for NeurAxis, unlocking the potential for large-scale insurance coverage for its flagship product, IB-Stim, and setting the stage for accelerated growth through evidence-based recommendations. 'We are thrilled that IB-Stim is now recognized as part of the standard of care for FAP in IBS,' said Brian Carrico, CEO of NeurAxis. 'This milestone offers new hope to patients and reinforces the strength of our short and long-term growth strategy. Alongside our recent FDA expanded clearances for IB-Stim and our transformative, soon-to-be-effective on January 1st, Category I CPT code, we are now well-positioned to drive substantial top-line growth and operational leverage.' He added, 'With the recent strengthening of our balance sheet and the expected rollout of more widespread insurance coverage, we are poised to accelerate our treatment option to the over 600,000 kids in the United States suffering from FAP. We estimate the addressable market for our product just in the US to be over 3 billion dollars. With these important achievements now completed, I expect that this achievement will lead to a significant expansion of insurance coverage and revenue generation.' Dr. Adrian Miranda, practicing pediatric gastroenterologist and Chief Medical Officer of NeurAxis, commented: 'Overall, consensus was reached by the committee on 25 therapies and PENFS with IB-Stim was 1 of 4 therapies that had the highest level of evidence and thus placed amongst the top in the treatment algorithm for FAP in IBS.' Dr. Miranda also added, 'IB-Stim is not available in Europe, so the treatment algorithm was formulated to establish a framework for 'shared decision making' amongst the clinician and family, as opposed to a strict top to bottom approach. This gives clinicians the option to use IB-Stim as a first-line therapy and speaks to the overall certainty of the efficacy and safety supporting our technology. We couldn't be more pleased with this result.' Developing practice guidelines for FAP in IBS in children of 4–18 years was a collaborative effort of the European and North American Societies for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN and NASPGHAN). The guidelines followed the 'Grading of Recommendations Assessment, Development and Evaluation' (GRADE) approach, which is supported by the World Health Organization (WHO). The highest GRADE therapies suggested in the guidelines include PENFS, hypnotherapy, lactobacillus rhamnosus (probiotic), and soluble fiber. This rigorous, evidence-based approach that incorporates PENFS as an important treatment option for children elevates NeurAxis's profile within the healthcare industry and supports wider market adoption of IB-Stim. Abdominal pain in IBS affects millions globally, creating a multi-billion-dollar market opportunity with limited effective treatment options. IB-Stim is the only pediatric treatment option that the FDA has cleared for FAP in IBS and abdominal pain in functional dyspepsia (to include nausea symptoms) for patients 8-21 years old. IB-Stim delivers gentle electrical impulses to cranial nerve bundles in the ear, offering a safe, non-invasive alternative to drug therapies often used off-label and many of which are not suggested in the practice guidelines from NASPGHAN / ESPGHAN. For more information about NeurAxis, please visit About NeurAxis, Inc., is a medical technology company focused on neuromodulation therapies to address chronic and debilitating conditions in children and adults. NeurAxis is dedicated to advancing science and leveraging evidence-based medicine to drive adoption of its IB-Stim™ therapy, which is its proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology, by the medical, scientific, and patient communities. IB-Stim™ is FDA cleared for functional abdominal pain associated with irritable bowel syndrome (IBS) in adolescents 8-21 years old. Additional clinical trials of PENFS in multiple pediatric and adult conditions with large unmet healthcare needs are underway. For more information, please visit Forward-Looking StatementsCertain statements in this press release are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical fact are forward-looking statements. Forward-looking statements are based on management's current assumptions and expectations of future events and trends, which affect or may affect the Company's business, strategy, operations or financial performance, and actual results and other events may differ materially from those expressed or implied in such statements due to numerous risks and uncertainties. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. There are a number of important factors that could cause actual results, developments, business decisions or other events to differ materially from those contemplated by the forward-looking statements in this press release. These factors include, among other things, the conditions in the U.S. and global economy, the trading price and volatility of the Company's stock, public health issues or other events, the Company's compliance with applicable laws, the results of the Company's clinical trials and perceptions thereof, the results of submissions to the FDA, and factors described in the Risk Factors section of NeurAxis's public filings with the Securities and Exchange Commission (SEC). Because forward-looking statements are inherently subject to risks and uncertainties, you should not rely on these forward-looking statements as predictions of future events. These forward-looking statements speak only as of the date of this press release and, except to the extent required by applicable law, the Company undertakes no obligation to update or revise these statements, whether as a result of any new information, future events and developments or otherwise. For more information, please visit For contraindications, precautions, warnings, and IFU, please see: Contacts: CompanyNeurAxis, Investor Relations Lytham PartnersBen Shamsian646-829-9701shamsian@
